NKp80/KLRF1 Antibody (239127) [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # FAB1900W
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Recombinant Monoclonal Rat IgG2A Clone # 239127
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human NKp80/KLRF1
Val66-Tyr231
Accession # Q9NZS2
Val66-Tyr231
Accession # Q9NZS2
Reactivity Notes
0
Specificity
Detects human NKp80/KLRF1 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) NKp30, rhNKp44, rhNKp46, or recombinant mouse NKp46 is observed.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Applications for NKp80/KLRF1 Antibody (239127) [DyLight 650]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: NKp80/KLRF1
Alternate Names
CLEC5C, KLRF1
Gene Symbol
KLRF1
Additional NKp80/KLRF1 Products
Product Documents for NKp80/KLRF1 Antibody (239127) [DyLight 650]
Product Specific Notices for NKp80/KLRF1 Antibody (239127) [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...